Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 101401-101450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04432597
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
PHASE1/PHASE2Active, not recruiting
39 participants
Started: Aug 11, 2020 · Completed: Nov 20, 2025
5 conditions1 sponsor1 location
NCT04162496
Restylane Refyne for Correction of Horizontal Neck Rhytides
NAActive, not recruiting
24 participants
Started: Aug 11, 2020 · Completed: Sep 30, 2021
3 conditions2 sponsors1 location
NCT04362527
Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage
PHASE3Recruiting
370 participants
Started: Aug 10, 2020 · Completed: Jan 11, 2026
1 condition1 sponsor16 locations
NCT04503551
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
PHASE3Active, not recruiting
174 participants
Started: Aug 10, 2020 · Completed: Jun 13, 2025
1 condition1 sponsor64 locations
NCT04501536
Determining Optimal Treatment Intensity for Children With Language Impairment
NAActive, not recruiting
59 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2025
1 condition2 sponsors2 locations
NCT04074382
FIT Study (Functional Outcomes In Trauma Study)
N/AActive, not recruiting
440 participants
Started: Aug 10, 2020 · Completed: Sep 30, 2032
11 conditions1 sponsor1 location
NCT04274179
Ketogenic Diet for New-Onset Absence Epilepsy
PHASE3Recruiting
40 participants
Started: Aug 10, 2020 · Completed: May 1, 2026
3 conditions1 sponsor1 location
NCT04482374
Puberty Suppression and Cardiometabolic Health
N/ARecruiting
30 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2026
4 conditions1 sponsor1 location
NCT04808596
Pulmonary Hypertension Biorepository and Registry
N/ARecruiting
300 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2027
9 conditions1 sponsor1 location
NCT04267588
Using Technology to Track Pain and Pain-related Outcomes
N/ARecruiting
100 participants
Started: Aug 10, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04469517
Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
N/ARecruiting
100 participants
Started: Aug 10, 2020 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06840262
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
NARecruiting
45 participants
Started: Aug 10, 2020 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT04333576
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
PHASE3Recruiting
800 participants
Started: Aug 10, 2020 · Completed: Jun 30, 2030
1 condition1 sponsor179 locations
NCT04204499
Analysis of Screen-detected Lung Cancers' Genomic Traits
N/ARecruiting
526 participants
Started: Aug 10, 2020 · Completed: Mar 30, 2026
1 condition1 sponsor2 locations
NCT04858958
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
PHASE1Active, not recruiting
30 participants
Started: Aug 10, 2020 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03764098
Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
PHASE2Recruiting
160 participants
Started: Aug 10, 2020 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT04176848
CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
PHASE2Active, not recruiting
15 participants
Started: Aug 10, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors5 locations
NCT04221477
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis
PHASE3Active, not recruiting
271 participants
Started: Aug 10, 2020 · Completed: Feb 28, 2028
1 condition1 sponsor73 locations
NCT06083649
The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal Disease
NARecruiting
100 participants
Started: Aug 10, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04510740
Liver Cancer Registry Platform
N/ARecruiting
1,000 participants
Started: Aug 9, 2020 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04466852
Brazilian Heart Insufficiency With Telemedicine
NARecruiting
720 participants
Started: Aug 8, 2020 · Completed: Dec 31, 2025
1 condition4 sponsors2 locations
NCT04204850
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
PHASE2Recruiting
20 participants
Started: Aug 7, 2020 · Completed: Dec 7, 2025
3 conditions2 sponsors1 location
NCT04304625
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
PHASE3Recruiting
1,380 participants
Started: Aug 7, 2020 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05376241
Promoting Informed Choice for Breast Cancer Screening
N/AActive, not recruiting
498 participants
Started: Aug 7, 2020 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT04169763
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
PHASE1Recruiting
25 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
6 conditions2 sponsors1 location
NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NARecruiting
28 participants
Started: Aug 7, 2020 · Completed: Apr 30, 2028
44 conditions2 sponsors2 locations
NCT04246333
Duodenal Feeds in Very Low Birth Weight Infants
NARecruiting
30 participants
Started: Aug 7, 2020 · Completed: Mar 31, 2026
6 conditions1 sponsor1 location
NCT04416269
Oral Anti Diabetic Agents in the Hospital
PHASE4Recruiting
260 participants
Started: Aug 7, 2020 · Completed: May 31, 2026
1 condition2 sponsors3 locations
NCT04472767
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
PHASE2Recruiting
35 participants
Started: Aug 7, 2020 · Completed: Sep 1, 2027
2 conditions2 sponsors1 location
NCT04395079
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
PHASE2Active, not recruiting
9 participants
Started: Aug 7, 2020 · Completed: Dec 1, 2026
4 conditions2 sponsors1 location
NCT04513483
CPAP in AF Patients With OSA
NAActive, not recruiting
100 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04946279
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
NAActive, not recruiting
98 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
5 conditions5 sponsors2 locations
NCT04227847
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
PHASE1Recruiting
178 participants
Started: Aug 7, 2020 · Completed: Jul 3, 2028
2 conditions1 sponsor54 locations
NCT04776941
Expressive Writing for the Management of Stress in Cancer Survivors
NARecruiting
414 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT04856501
A Randomized Control Trial of a Responsive Parenting Intervention to Support Healthy Brain Development and Self-regulation in Toddlers Born Preterm
NARecruiting
300 participants
Started: Aug 7, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT04703699
Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
N/ARecruiting
200 participants
Started: Aug 7, 2020 · Completed: Nov 30, 2028
1 condition1 sponsor8 locations
NCT04189757
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
PHASE2Active, not recruiting
9 participants
Started: Aug 7, 2020 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04514029
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
EARLY_PHASE1Active, not recruiting
37 participants
Started: Aug 6, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03146546
STUDY00015328: Sepsis Endotypes
N/AEnrolling by invitation
200 participants
Started: Aug 6, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04240756
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
PHASE3Active, not recruiting
240 participants
Started: Aug 6, 2020 · Completed: Jul 31, 2025
2 conditions5 sponsors1 location
NCT04430192
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Aug 6, 2020 · Completed: Aug 30, 2025
1 condition5 sponsors1 location
NCT04432285
Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia
N/AEnrolling by invitation
50 participants
Started: Aug 6, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04195451
Re-Energize Fontan
NARecruiting
150 participants
Started: Aug 6, 2020 · Completed: Mar 1, 2026
1 condition3 sponsors1 location
NCT05334290
Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment
N/ARecruiting
400 participants
Started: Aug 6, 2020 · Completed: Aug 5, 2024
1 condition1 sponsor1 location
NCT04341350
Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation
PHASE3Recruiting
250 participants
Started: Aug 6, 2020 · Completed: Aug 31, 2026
1 condition1 sponsor12 locations
NCT05200715
AutoInflammatory Disease Alliance Registry (AIDA)
N/ARecruiting
3,500 participants
Started: Aug 6, 2020 · Completed: Aug 6, 2030
11 conditions1 sponsor112 locations
NCT04300556
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
PHASE1/PHASE2Recruiting
182 participants
Started: Aug 6, 2020 · Completed: Aug 8, 2030
1 condition1 sponsor58 locations
NCT04356729
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
PHASE2Active, not recruiting
30 participants
Started: Aug 6, 2020 · Completed: Sep 1, 2026
4 conditions2 sponsors3 locations
NCT04477629
Belatacept in De Novo Heart Transplantation
PHASE2Recruiting
12 participants
Started: Aug 6, 2020 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT04079712
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors
PHASE2Active, not recruiting
17 participants
Started: Aug 6, 2020 · Completed: Jul 14, 2026
4 conditions1 sponsor46 locations